Alloantiserum-mediated suppression of histocompatibility-linked IR gene controlled immune responses. I. Histocompatibility antigen requirement.
D000409:Alanine; D000818:Animals; D000941:Antigens; D001202:Ascitic Fluid / Q000166:cytology; D002860:Chromium Radioisotopes; D003601:Cytotoxicity Tests, Immunologic; D004247:DNA / Q000096:biosynthesis; D004140:Dinitrophenols; D005971:Glutamates; D006168:Guinea Pigs; D006649:Histocompatibility Antigens; D007106:Immune Sera; D007114:Immunization; D007125:Immunogenetics; D007165:Immunosuppression Therapy; D007518:Isoantibodies; D037102:Lectins; D008213:Lymphocyte Activation; D008214:Lymphocytes / Q000276:immunology*; D008239:Lysine; D012882:Skin Tests; D013045:Species Specificity; D013936:Thymidine / Q000378:metabolism; D014316:Tritium; D014443:Tyrosine
D000941:Antigens; D002860:Chromium Radioisotopes; D004140:Dinitrophenols; D005971:Glutamates; D006649:Histocompatibility Antigens; D007106:Immune Sera; D007518:Isoantibodies; D037102:Lectins; D014316:Tritium; D014443:Tyrosine; D004247:DNA; D008239:Lysine; D000409:Alanine; D013936:Thymidine